News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
World’s Largest Cell and Gene Therapy Plant Opens
Catherine Offord | Apr 11, 2018
Lonza will employ more than 200 full-time staff to work at the Texas-based facility, the company says.
Puerto Rico’s Hurricane Damage May Mean Drug Shortages
Ashley P. Taylor | Oct 11, 2017
Three weeks after Hurricane Maria hit the island, pharmaceutical plants are not back up to speed.
Daraprim Discounts Offered
Karen Zusi | Nov 26, 2015
Turing Pharmaceuticals will soon offer discounts to hospitals for its toxoplasmosis-fighting drug, the company announced, but some say the proposed price reductions are not enough.
Novartis Linked to Retracted Papers?
Dan Cossins | Apr 2, 2013
A Japanese newspaper claims that the pharma giant funded flawed research that revealed extra health benefits for one of its top-selling drugs.
Regulations for Biosimilars
Lisa A. Haile and Kimberly K. Egan | Jun 1, 2012
As biologic drug patents begin to expire, generic versions will hit the market—but how will they be regulated?
Bogus Isomer Vendors Identified
Sabrina Richards | May 25, 2012
Pharma company publishes a list of 17 companies known to have sold the incorrect isomer of the kinase inhibitor bosutinib.
Mismarketed Chemical Causes Concern
Sabrina Richards | May 13, 2012
An incorrect isomer of the kinase inhibitor bosutinib is circulating in the biomedical research community, potentially throwing doubt on study results.
A Bill to Expedite Drug Production
Jef Akst | Feb 2, 2012
Legislation proposes speeding certain drug applications submitted to the US Food and Drug Administration.